Detalhe da pesquisa
1.
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy.
J Transl Med;
16(1): 343, 2018 12 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30522500
2.
Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.
Int J Antimicrob Agents;
63(6): 107164, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38574873
3.
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks).
Viruses;
14(3)2022 03 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35336931
4.
Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.
J Int AIDS Soc;
24(5): e25732, 2021 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34036745
5.
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort.
PLoS One;
14(8): e0221231, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31469856
6.
Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients.
Antiviral Res;
121: 94-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26122170
7.
Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc.
J Int AIDS Soc;
17(4 Suppl 3): 19726, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25397472